ArticleInternational journal of hematology2025
Venetoclax and azacitidine in combination with homoharringtonine, cytarabine, and aclarubicin for salvage therapy of relapsed/refractory T cell acute lymphoblastic leukemia.
Lin-Sen Feng et al.PubMed ↗Publisher ↗
No numbers read from the abstract.